StemPoint Capital LP CRNX Holdings History
StemPoint Capital LP's Crinetics Pharmaceuticals Inc Holding Summary
As of 2025-03-31, StemPoint Capital LP held - shares of Crinetics Pharmaceuticals Inc(CRNX), totaling N/A. This investment constitutes 0% of their stock portfolio, and StemPoint Capital LP now holds 0% of the outstanding Crinetics Pharmaceuticals Inc(CRNX) stock.
The initial trade took place in 2023Q4. And since then StemPoint Capital LP has made 2 purchases of CRNX, at an average price of $38.62, for a total of 723,034.00 shares. In addition, there have been 3 sales at an average price of $44.82 for 723,034.00 shares. Based on historical transaction data and CRNX's current price of $32.98, StemPoint Capital LP's estimated gain on his CRNX holdings is $4.48 Mil, reflecting a 16.06% gain to date.
StemPoint Capital LP CRNX ($32.98) Holding Chart
StemPoint Capital LP CRNX ($32.98) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
